Xiu-Bao Ren

Xiu-Bao Ren

Auto-generated profile, based on publicly available information

Xiu-Bao Ren

Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin 300060, China

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2012 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
LYLili Yang
Lili Yang
BRBaozhu Ren
Baozhu Ren
HLHui Li
Hui Li
JYJinpu Yu
Jinpu Yu
SCShui Cao
Shui Cao
XRXiubao Ren
Xiubao Ren


30 November 2010 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
XRXiubao Ren
Xiubao Ren
RZRupeng Zhang
Rupeng Zhang
HLHui Li
Hui Li
YJYU Jinpu
YU Jinpu
JZJingzhu Zhao
Jingzhu Zhao
QXQiang Xue
Qiang Xue
To study the role of indoleamine 2,3-dioxygenase (IDO) in immune response and immune escape in gastric cancer, the human IDO gene was cloned by reverse transcription-polymerase chain reaction (RT-PCR) and inserted into the pIRES2-EGFP vector to construct the IDO expression vector (pIRES2-EGFP-IDO). BGC-823 cells were transfected with the vector by electroporation and selected stable expression with G418. IDO expression was determined by RT-PCR and Western blot analysis. The enzymatic activity of IDO was estimated by determining tryptophan and kynurenine concentrations in the cell culture medium by an amino acid analyzer. To assess the effect of IDO on T cell-mediated cytotoxicity and proliferation, T cells from patients with gastric cancer were co-cultured with the IDO-transfected BGC-823 cells in the presence or absence of 1-MT, a competitive inhibitor of IDO. Cells transfected with the vector expressed high levels of IDO mRNA and protein, and a significantly higher level of kynurenic acid was detected in the culture medium of the transfected cells compared to the non-transfected cells (P<0.001). T cells co-cultured with the IDO-transfected cells exhibited significantly lower cytotoxicity compared to the control group (P<0.05). Additionally, IDO-transfected cells treated with 1-MT exhibited higher toxicity compared to the untreated IDO-transfected cells (P<0.01). We conclude that IDO plays a key role in gastric cancer immune suppression, possibly by inhibiting T cell-mediated cytotoxicity and proliferation in vitro.


1 January 2009 in Cytotherapy
Verified
Journal Article
Closed access
HLHui Li
Hui Li
CWChangli Wang
Changli Wang
YJYU Jinpu
YU Jinpu
SCShui Cao
Shui Cao
FWFeng Wei
Feng Wei
XRXiu-Bao Ren
Xiu-Bao Ren

1 July 2011
Verified
Journal Article
Closed access
JLJun-Tian Liu
Jun-Tian Liu
LWLi-Juan Wei
Li-Juan Wei
YJYU Jinpu
YU Jinpu
HLHui Li
Hui Li
RLRun-Mei Li
Run-Mei Li
XRXiu-Bao Ren
Xiu-Bao Ren